At Duke University, Durham, NC, the Center for In Vivo Microscopy (CIVM) has recently ordered a MILabs U-SPECT-II/CT system to enhance their comprehensive program dedicated to developing novel methods for preclinical imaging, focusing on the highest possible spatial resolution and applying those methods to important biomedical problems. The CIVM is a NIH/NCRR-funded National Biomedical Technology Research Center led by G. Allan Johnson, PhD, the Charles E. Putman Distinguished Professor of Radiology and Professor of Biomedical Engineering and Physics at Duke University.
Dr. Johnson’s research involves magnetic resonance histology (MRH), the application of MR microscopy to study tissue architecture. Dr. Johnson and his colleagues were the first to suggest the use of MRH for morphologic phenotyping in mice and he plans to integrate the ultra-high resolution SPECT imaging of the U-SPECT-II/CT to expand on his current work with MRH.